Table 1: Baseline clinical and biochemical
characteristics of obese adolescents according to gender.
|
Variable |
Female (n = 24) |
Male (n = 14) |
p |
|
Age (years) |
13.2 ± 0.7 |
12.8 ± 0.7 |
0.16 |
|
BMI
(kg/m2) |
32.0
± 3.7 |
29.6
± 3.3 |
0.04 |
|
%
Bodyfat |
40.9
± 2.7 |
32.7
± 6.7 |
0.006 |
|
Glucose*
(mg/dL) |
90.6 ± 8.8 |
97.7 ± 9.0 |
0.001 |
|
Insulin$
(mU/mL) |
6.2
(3.1-9.4) |
4.9
(1.7-8.2) |
0.04 |
|
HOMA-IR |
1.3
(0.7-2.0) |
1.1
(0.4-1.9) |
0.11 |
|
Leptin (ng/mL) |
24.3
(17.4-32.3) |
19.9 (15.2-22.1) |
0.08 |
|
Adiponectin
(ng/mL) |
12.7 (4.9-22.7) |
6.3 (2.5-12.9) |
0.16 |
|
FVC
(liters) |
3.576
± 0.6 |
3.650
± 0.8 |
0.08 |
|
FVC
(% predicted) |
114.8
± 19.5 |
111.0
± 12.5 |
0.4 |
|
FEV1
(liters) |
3.029
± 0.5 |
2.955
± 0.6 |
0.17 |
|
FEV1
(% predicted) |
153.4
± 22.3 |
105.6
± 14.6 |
0.17 |
|
FEV1/FVC% |
84.7
± 5.2 |
82.1
± 6.1 |
0.48 |
|
PEF
(liters) |
6.587
± 1.37 |
6.605
± 1.5 |
0.43 |
|
PEF
(% predicted) |
107.0
± 22.0 |
104.0
± 19.6 |
0.11 |
|
SBP
(mmHg) |
127.5
± 8.5 |
125.3
± 7.7 |
0.44 |
|
DBP
(mmHg) |
86.6
± 7.3 |
82.1
± 5.0 |
0.04 |
|
VO2max (mL/kg/min) |
16.3
± 3.7 |
19.3
± 3.5 |
0.01 |
|
HR
(bpm) |
91.4 ± 16.0 |
97.8 ± 9.6 |
0.26 |
|
SDNN
(ms) |
83.5
(67.9-99.1) |
65.7
(51.9-79.6) |
0.07 |
|
LF/HF |
3.6 (3.0-4.3) |
5.0 (3.8-6.3) |
0.15 |
Variables
are shown as mean± SD or mean (95%
CI).
p: difference between genders.
*Glucose
conversion factor to SI 0.05551; $Conversion factor to SI 7.175.
HOMA-IR: homeostatic
model assessment-insulin resistance index.
FVC: forced
vital capacity
FEV1:
forced expiratory volume at 1 second
FEV1/FVC:
forced expiratory volume at 1 second/forced vital capacity
PEF: peak
expiratory flow
SBP:
systolic blood pressure
DBP: diastolic
blood pressure
VO2max:
maximal oxygen intake
SDNN:
standard deviation of all the normal R_R intervals
LF/HF:
low-frequency/high-frequency index.